About The Webinar
Biopharma and life sciences companies face unique challenges when valuing their clinical trial materials in compliance with U.S. customs valuation regulations. These valuation decisions can have significant impacts on the amount of duties and tariffs owed, particularly in today’s volatile trade policy environment. This webinar will provide an overview of basic U.S. customs law valuation principles and highlights specific areas relevant for clinical trials.
Speaker

ANDREA K. JEGLUM is an associate with Sandler, Travis & Rosenberg, P.A., located in the Boston area. She concentrates her practice on customs compliance matters including tariff classification, country of origin, valuation, trade agreements, foreign-trade zones, and duty reduction programs. She also helps clients meet U.S. requirements concerning trade in biopharma, agro-chemicals, and animal products, including endangered species, as well as export filings and enforcement measures.
Key Topics
- The World Customs Organization’s Customs Valuation Agreement
- Basic concepts of customs valuation
- Valuation tools and resources
- Valuation Methods
- Clinical Trial Valuation Examples
- Best Practices for Clinical Trial Valuation and Recordkeeping